CompletedN/Aketamine

Cognitive Recovery After Electroconvulsive Therapy and General Anesthesia

Sponsored by Washington University School of Medicine

NCT ID
NCT02761330
Target Enrollment
17 participants
Start Date
2016-04
Est. Completion
2019-09-11

About This Study

This study is geared toward characterizing the recovery of brain activity and cognitive function following treatments of electroconvulsive therapy and ketamine general anesthesia.

Conditions Studied

DepressionDeliriumSeizuresCognitive Disorders

Interventions

  • Ketamine
  • Electroconvulsive Therapy

Eligibility

Age:18 Years - 60 Years
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria:

* Treatment resistant depression requiring outpatient ECT
* Planned right unilateral ECT stimulation
* English speaking
* Able to provide written informed consent

Exclusion Criteria:

* Known brain lesion or neurological illness that causes cognitive impairment
* Schizophrenia
* Schizoaffective disorder
* Blindness or deafness or motor impediments that may impair performance for cognitive testing battery
* Inadequate ECT seizure duration with etomidate

Study Locations (1)

Washington University School of Medicine
St Louis, Missouri, United States

This trial is not recruiting

This study has completed enrollment. Check back for results or find similar trials.

Find recruiting trials
Data Source
ClinicalTrials.gov

Last updated from source